Literature DB >> 2968203

Defective autologous mixed leukocyte reaction in newly diagnosed type 1 diabetes mellitus.

L Räsänen1, H Hyöty, M Lehto, O P Kallioniemi, J Antonen, T Huupponen, J Karjalainen, P Leinikki.   

Abstract

We studied autologous mixed leukocyte reaction (AMLR) in type 1 (insulin-dependent) diabetes mellitus (IDDM) patients, their healthy siblings and healthy schoolchildren, Blood samples from the patients were drawn within 1 week after hospitalization and 2 months later. AMLR was significantly depressed in the patients when compared to healthy siblings or other healthy controls. In addition, the mean AMLR responsiveness of the healthy control group exceeded that of healthy siblings. The production of IL-2 in AMLR was impaired in the patient group and the defective AMLR could be restored by addition of exogenous IL-2 in 7-10 patient cultures. However, in 3-10 patients addition of IL-2 induced no enhancement of proliferation. While the patients in general had raised levels of activated T lymphocytes these three patients had higher numbers of activated T cells than other patients. Defective AMLR and presence of activated T cells may be related and may play a role in the pathogenesis of IDDM.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968203      PMCID: PMC1541663     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  17 in total

1.  T cells from patients with chronic liver diseases: abnormalities in PHA-induced expression of HLA class II antigens and in autologous mixed-lymphocyte reactions.

Authors:  M Scudeletti; F Indiveri; I Pierri; A Picciotto; S Ferrone
Journal:  Cell Immunol       Date:  1986-10-01       Impact factor: 4.868

2.  Cytochemical identification of monocytes and granulocytes.

Authors:  L T Yam; C Y Li; W H Crosby
Journal:  Am J Clin Pathol       Date:  1971-03       Impact factor: 2.493

3.  The human autologous mixed lymphocyte reaction. III. Immune circuits.

Authors:  J S Smolen; T M Chused; E A Novotny; A D Steinberg
Journal:  J Immunol       Date:  1982-09       Impact factor: 5.422

4.  Increased circulating Ia-antigen-bearing T cells in type I diabetes mellitus.

Authors:  R A Jackson; M A Morris; B F Haynes; G S Eisenbarth
Journal:  N Engl J Med       Date:  1982-04-01       Impact factor: 91.245

5.  HLA-Dw1 and BfF as protective markers in multiple sclerosis.

Authors:  J Ilonen; A Lagerstedt; S Koskimies; M Reunanen
Journal:  J Neuroimmunol       Date:  1983-12       Impact factor: 3.478

6.  Culture and phenotype of activated T-cells from patients with type I diabetes mellitus.

Authors:  A R Hayward; M Herberger
Journal:  Diabetes       Date:  1984-04       Impact factor: 9.461

7.  Decreased synthesis of interleukin-2 (IL-2) in insulin-dependent diabetes mellitus.

Authors:  K S Zier; M M Leo; R S Spielman; L Baker
Journal:  Diabetes       Date:  1984-06       Impact factor: 9.461

Review 8.  Autologous mixed lymphocyte reaction in health and disease states in man.

Authors:  S Gupta
Journal:  Vox Sang       Date:  1983       Impact factor: 2.144

9.  Autologous mixed lymphocyte reaction in man. VI. Deficiency of autologous mixed lymphocyte reaction in type I (insulin-dependent) diabetes mellitus.

Authors:  S Gupta; S Fikrig; E Orti
Journal:  J Clin Lab Immunol       Date:  1983-06

10.  An association between complement-fixing cytoplasmic islet cell antibodies and endogenous insulin secretion in children with insulin-dependent diabetes mellitus.

Authors:  A Mustonen; M Knip; H K Akerblom
Journal:  Diabetes       Date:  1983-08       Impact factor: 9.461

View more
  4 in total

1.  Impairment of autologous mixed lymphocyte reaction in the spleen and peripheral blood lymphocytes of patients with idiopathic portal hypertension.

Authors:  H Yamaue; H Tanimura; M Iwahashi; T Tsunoda; M Tani; M Tamai; M Inoue
Journal:  Gastroenterol Jpn       Date:  1990-04

Review 2.  Mouse models for the study of autoimmune type 1 diabetes: a NOD to similarities and differences to human disease.

Authors:  John P Driver; David V Serreze; Yi-Guang Chen
Journal:  Semin Immunopathol       Date:  2010-04-28       Impact factor: 9.623

3.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

Review 4.  Mechanisms of autoimmunity in type I diabetes.

Authors:  D Faustman
Journal:  J Clin Immunol       Date:  1993-01       Impact factor: 8.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.